Search results for "Metastase"

showing 10 items of 145 documents

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controv…

2016

Contains fulltext : 171468pub.pdf (Publisher’s version ) (Open Access) Primary treatment of rectal cancer was the focus of the second St. Gallen European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Cancer Conference. In the context of the conference, a multidisciplinary international expert panel discussed and voted on controversial issues which could not be easily answered using published evidence. Main topics included optimal pretherapeutic imaging, indication and type of neoadjuvant treatment, and the treatment strategies in advanced tumours. Here we report the key recommendations and summarise the related evidence. The treatment strategy for localised rect…

Cancer ResearchStagingColorectal cancermedicine.medical_treatmentNeoplasias Gastrointestinais030230 surgerySYNCHRONOUS LIVER METASTASESImagingCOLORECTAL-CANCER0302 clinical medicineADJUVANT CHEMOTHERAPYTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]SHORT-COURSE RADIOTHERAPYRectal cancerNeoadjuvant therapyGastrointestinal NeoplasmsRectal Neoplasms/drug therapyCombination chemotherapyChemoradiotherapyCombined Modality TherapyTotal mesorectal excisionNeoadjuvant TherapyEuropeNeoplasias do Recto/quimioterapiaOncology030220 oncology & carcinogenesisMEDIAN FOLLOW-UPLife Sciences & BiomedicineDiagnostic Imagingmedicine.medical_specialtyAntineoplastic AgentsLOCAL RECURRENCERisk AssessmentCOURSE PREOPERATIVE RADIOTHERAPY03 medical and health sciencesmedicineHumansGastrointestinal cancerOncology & CarcinogenesisRadiochemotherapyNeoplasm StagingScience & TechnologyRadiotherapyRectal Neoplasmsbusiness.industryGeneral surgeryTOTAL MESORECTAL EXCISIONCancerRANDOMIZED PHASE-IIImedicine.diseaseSurgeryRadiation therapySurgerybusiness1112 Oncology And CarcinogenesisChemoradiotherapyPOSTOPERATIVE CHEMORADIOTHERAPY
researchProduct

A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer:…

2021

PURPOSE/OBJECTIVE(S): stereotactic ablative radiotherapy (SABR) has been shown to increase survival rates in oligometastatic disease (OMD), but local control of colorectal metastases still remains poor. We aimed to identify potential predictive factors of SBRT response through a multicenter large retrospective database and to investigate how lung SBRT can impact on the progression to the polymetastatic disease (PMD). MATERIALS/METHODS: the study involved 22 centers, and was approved by the Ethical Committee (Prot. Negrar 2019-ZT). 1023 lung metastases treated with SBRT in 622 patients were reported. The median BED was 105 Gy10. Lesion diameter GTV, PTV volume, dose, fractionations, and site…

Cancer ResearchUnivariate analysismedicine.medical_specialtyRadiationPredictive markerColorectal cancerbusiness.industrymedicine.medical_treatmentmedicine.disease_causemedicine.diseaseSABR volatility modelPrimary tumorRadiation therapyLesioncolorectal metastaseOncologymedicineRadiology Nuclear Medicine and imagingKRASRadiologyoligometastasemedicine.symptombusinessSABRInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic c…

2019

480 Background: Hepatic metastasectomy is the only potential curative treatment option for stage IV colorectal cancer (CRC) limited to liver metastases (LM). After R0 resection of LM the high recurrence rate remains a major challenge. L-BLP25 is an antigen-specific cancer vaccine targeting mucin 1 (MUC1). The LICC trial aimed to improve survival outcome in mCRC patients (pts) after R0/R1 LM resection. Methods: This LICC trial, a binational, multicenter, double-blinded, placebo controlled phase II trial, included pts with stage IV LM limited CRC after resection of primary tumor and LM (R0/R1) within the last 8 weeks, ECOG 0/1 and adequate organ function. Pts were 2:1 randomized to receive L…

Cancer Researchmedicine.medical_specialtyColorectal cancerDouble blindedbusiness.industrymedicine.medical_treatmentImmunotherapyPlacebomedicine.diseaseGastroenterologyOncologyInternal medicinemedicineTecemotideMetastasectomybusinessAdjuvantR0 resectionJournal of Clinical Oncology
researchProduct

Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials ( LICC , CEL…

2021

Metastatic colorectal cancer (mCRC) patients with liver-limited disease (LLD) have a chance of long-term survival and potential cure after hepatic metastasectomy. However, the appropriate postoperative treatment strategy is still controversial. The CELIM and FIRE-3 studies demonstrated that secondary hepatic resection significantly improved overall survival. The objective of this analysis was to compare these favorable outcome data with recent results from the LICC trial investigating the antigen-specific cancer vaccine tecemotide (L-BLP-25) as adjuvant therapy in mCRC patients with LLD after R0/R1 resection. Data from mCRC patients with LLD and secondary hepatic resection from each study w…

Cancer Researchmedicine.medical_specialtyColorectal cancerbusiness.industryDiseasemedicine.diseaseResectionSurgeryOncologyCohortmedicineAdjuvant therapyTecemotideCancer vaccineMetastasectomybusinessInternational Journal of Cancer
researchProduct

Wider implications of video-assisted thoracic surgery versus open approach for lung metastasectomy

2015

ABSTRACT  Lung metastasectomy is considered a safe and potentially curative procedure despite there is not a strong evidence that metastasectomy prolongs long-term survival in patients with lung metastases. Moreover, the debate is open regarding the best approach for lung metastasectomy, video-assisted thoracic surgery versus open approach. A systematic review of literature to clarify what is the best approach to prolong survival in patients with lung metastases was performed. Our study confirms that overall survival is equivalent for video-assisted thoracic surgery and thoracotomy, therefore the ‘gold standard’ surgical treatment for lung metastases remains a point of debate. The choice o…

Cancer Researchmedicine.medical_specialtyLung Neoplasmslung metastasectomymedicine.medical_treatmentSettore MED/21 - Chirurgia ToracicaSingle Centersurvivallunglaw.inventionRandomized controlled triallawmedicineHumanspulmonary metastasesThoracotomyLungThoracic Surgery Video-Assistedbusiness.industryGeneral surgeryGold standardgold standardMetastasectomyGeneral Medicinegold standard lung lung metastasectomy pulmonary metastases survival thoracotomy VATS video-assisted thoracic surgerygold standard; lung; lung metastasectomy; pulmonary metastases; survival; thoracotomySurgerymedicine.anatomical_structureThoracotomyOncologyCardiothoracic surgeryVideo assisted thoracic surgeryMetastasectomybusiness
researchProduct

A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial immunotherapy with L-BLP25 (tecemotide) in patients with c…

2013

TPS3124^ Background: 15-20% of all patients (pts) diagnosed with colorectal cancer (crc) develop metastases (mets) surgical resection remains the only potentially curative treatment available. Current 5-year survival rate following R0 resection of liver mets lies between 28-39%, recurrence occurs in up to 70% of pts. To date, adjuvant chemotherapy has not significantly improved clinical outcomes. The primary objective of the ongoing LICC trial (L-BLP25 In Colorectal Cancer) is to determine whether L-BLP25, an active MUC1-specific cancer immunotherapy, extends recurrence-free survival (RFS) time over placebo in crc pts following R0/R1 resection of liver mets known to highly express MUC1 gly…

Cancer Researchmedicine.medical_specialtybusiness.industryColorectal cancermedicine.medical_treatmentImmunotherapymedicine.diseasePlaceboGastroenterologySurgeryDouble blindOncologyCurative treatmentInternal medicineMedicineTecemotideIn patientMetastasectomybusinessJournal of Clinical Oncology
researchProduct

Sentinel lymph node biopsy in T1/T2 squamous cell carcinomas of the tongue: A prospective study

2014

Commonly used staging procedures often cannot predict the absence of cervical metastases (CM) in squamous cell carcinomas (SCCs) of the oral cavity. Due to the high incidence of occult CM in numerous N0 cases in the clinic, an elective neck dissection (ND) is performed. The sentinel lymph node biopsy (SNB) is a common concept in the modern surgical therapy of malignancies. The present study evaluates the applicability of this concept for T1/T2-SCC of the tongue. In a prospective clinical study, 10 consecutive patients with T1/T2-SCC of the tongue and cN0 necks, were enrolled. Following sentinel lymph node (SLN) scintigraphy, all patients underwent SNB with a γ-probe and a subsequent ND. SNB…

Cancer Researchmedicine.medical_specialtymedicine.medical_treatmentSentinel lymph nodecervical metastasesScintigraphy03 medical and health sciencessentinel lymph node0302 clinical medicineTongueBiopsymedicine030223 otorhinolaryngologyProspective cohort studymedicine.diagnostic_testbusiness.industryCancerNeck dissectionArticlesoral cancermedicine.diseaseOccultSurgerymedicine.anatomical_structuresquamous cell carcinoma of the tongueOncology030220 oncology & carcinogenesisbusinessOncology Letters
researchProduct

Association between Pterostilbene and Quercetin Inhibits Metastatic Activity of B16 Melanoma

2005

AbstractInhibition of cancer growth by resveratrol (trans-3,5,4'trihydroxystilbene; RESV), a phytoalexin present in many plant species, is limited by its low bioavailability. Pterostilbene (3,5-dimethoxy-4'-hydroxystilbene; PTER) and quercetin (3,3',4',5,6-pentahydroxyflavone; QUER), two structurally related and naturally occurring small polyphenols, show longer half-life in vivo. In vitro growth of highly malignant B16 melanoma F10 cells (B16M-F10) is inhibited (56%) by short-time exposure (60 min/day) to PTER (40 μM) and QUER (20 μM) (approximate mean values of plasma concentrations measured within the first hour after intravenous administration of 20 mg/kg of each polyphenol). Intravenou…

Cancer ResearchpterostilbenePterostilbeneEndotheliumMelanomaPolyphenolsResveratrolPharmacologymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282quercetinchemistry.chemical_compoundmedicine.anatomical_structurechemistryBiochemistryIn vivomedicinemelanomaVCAM-1Cell adhesionQuercetinmetastasesNeoplasia: An International Journal for Oncology Research
researchProduct

The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorect…

2021

BACKGROUND Cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC) represent the most effective strategy to manage peritoneal metastases (PM). This systematic review and meta-analysis aimed to assess the impact of body composition on clinical outcomes in patients with PM. METHODS A systematic literature search was performed using Medline, Web of Science and EMBASE databases from inception to the 20st August 2020. Data were independently extracted by 3 authors. Newcastle-Ottawa Scale was used to assess quality and risk of bias of studies. Pooled analyses were performed using Mantel-Haenszel method to estimate overall effect size with mean differences or odd ratios (O…

Clinical nutritionSarcopeniamedicine.medical_specialtyColorectal cancerSettore MED/18 - CHIRURGIA GENERALEMEDLINESettore MED/49 - SCIENZE TECNICHE DIETETICHE APPLICATEHyperthermic Intraperitoneal ChemotherapyClinical nutritionBody compositionPostoperative ComplicationsClinical outcomesInternal medicineHumansMedicineProspective StudiesMuscle SkeletalPeritoneal NeoplasmsHIPECbusiness.industryPostoperative complicationSkeletal muscleCytoreduction Surgical ProceduresHyperthermia InducedGeneral MedicinePrognosismedicine.diseaseCombined Modality TherapyConfidence intervalSurvival RatePeritoneal metastasesmedicine.anatomical_structureOncologyMeta-analysisSarcopeniaSurgeryColorectal NeoplasmsbusinessEuropean Journal of Surgical Oncology
researchProduct

An Osirix based plug-in for the study of dimensional and densitometric changes of hepatic metastases on CT images

2014

Aims and objectives Methods and materials Results Conclusion Personal information References

Computer Applications-Generalgenetic structuresComputer applications CT Computer Applications-General MetastasesComputer applicationsMetastasesCT
researchProduct